Year |
Citation |
Score |
2022 |
Gupta MK, Chiranjivi AK, Dutta T, Dubey VK, Rangan L. Synthesis and characterization of zinc derivatized 3, 5-dihydroxy 4', 7-dimethoxyflavone and its anti leishmaniasis activity against Leishmania donovani. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 35141791 DOI: 10.1007/s10534-022-00364-x |
0.459 |
|
2020 |
Saha G, Chiranjivi AK, Khamar BM, Prerna K, Kumar M, Dubey VK. BLIMP-1 Mediated Downregulation of TAK1 and p53 Molecules Is Crucial in the Pathogenesis of . Frontiers in Cellular and Infection Microbiology. 10: 594431. PMID 33194842 DOI: 10.3389/fcimb.2020.594431 |
0.62 |
|
2020 |
Chiranjivi AK, Prakash J, Saha G, Chandra P, Dubey VK. Mutational studies on Leishmania donovani dihydrolipoamide dehydrogenase (LdBPK291950.1) indicates that the enzyme may not be classical class-I pyridine nucleotide-disulfide oxidoreductase. International Journal of Biological Macromolecules. PMID 32750477 DOI: 10.1016/J.Ijbiomac.2020.07.236 |
0.572 |
|
2018 |
Prakash J, Yadav S, Saha G, Chiranjivi AK, Kumar S, Sasidharan S, Saudagar P, Dubey VK. Episomal expression of human glutathione reductase (HuGR) in Leishmania sheds light on evolutionary pressure for unique redox metabolism pathway: Impaired stress tolerance ability of Leishmania donovani. International Journal of Biological Macromolecules. PMID 30316767 DOI: 10.1016/J.Ijbiomac.2018.10.036 |
0.629 |
|
2018 |
Baranwal A, Chiranjivi AK, Kumar A, Dubey VK, Chandra P. Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania. Scientific Reports. 8: 8814. PMID 29891923 DOI: 10.1038/S41598-018-27170-1 |
0.506 |
|
2018 |
Chiranjivi AK, Dubey VK. Dihydrolipoamide dehydrogenase from Leishmania donovani: New insights through biochemical characterization. International Journal of Biological Macromolecules. PMID 29466712 DOI: 10.1016/J.Ijbiomac.2018.02.112 |
0.482 |
|
2017 |
Bhalla P, Sultana S, Chiranjivi AK, Saikia AK, Dubey VK. Synthesis of Methyl 4-(7-hydroxy-4,4,8-trimethyl-3-oxabicyclo[3.3.1]nonan-2-yl)benzoate and their evaluation as anti-leishmanial: Synergistic effect with Miltefosine. Antimicrobial Agents and Chemotherapy. PMID 29133553 DOI: 10.1128/Aac.01810-17 |
0.514 |
|
2017 |
Bhardwaj R, Das M, Singh S, Chiranjivi AK, Prabhu SV, Singh SK, Dubey VK. Evaluation of CAAX prenyl protease II of Leishmania donovani as potential drug target: Infectivity and growth of the parasite is significantly lowered after the gene knockout. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28279761 DOI: 10.1016/J.Ejps.2017.03.005 |
0.506 |
|
Show low-probability matches. |